Genomics BioSci & Tech. Co.,Ltd.
4195.TWO
Price:
$24.7
Market Cap:
$1.79B
Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company. It offers regular DNA, complex sequence, and TAF certificated sequencing services, as well as free sequencing primer and primer walking services; peptide, gene, and oligo synthesis services; and sample preparation, gene expression analysis, genotyping analysis, DNA methylation analysis, and microbial identification services. The company also provides genome level, targeted, gene regulation, and metagenomic sequencing services; third generation sequencing services; sequencing platforms and workflow; and non-invasive prenatal test, spinal muscular atrophy carrier screening, and fragile X syndrome premutation screening se...[Read more]
Industry
Biotechnology
IPO Date
2013-12-16
Stock Exchange
TWO
Ticker
4195.TWO
PE Ratio
[-21.48]
ROE
[-31.04%]
Current Ratio
[1.35]
Dividend Yield
[0%]
Enterprise Value
[2.26B]
Dividend History
The ROE as of December 2025 (TTM) for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) is -31.04%
According to Genomics BioSci & Tech. Co.,Ltd.’s latest financial reports and current stock price. The company's current ROE is -31.04%. This represents a change of 138.69% compared to the average of -13.00% of the last 4 quarters.
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) Historical ROE (quarterly & annually)
How has 4195.TWO ROE performed in the past?
The mean historical ROE of Genomics BioSci & Tech. Co.,Ltd. over the last ten years is -8.01%. The current -31.04% ROE has changed 287.49% with respect to the historical average. Over the past ten years (40 quarters), 4195.TWO's ROE was at its highest in in the June 2021 quarter at 1.39%. The ROE was at its lowest in in the December 2024 quarter at -28.13%.
Average
-8.01%
Median
1.36%
Minimum
-40.66%
Maximum
9.07%
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Genomics BioSci & Tech. Co.,Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.90%
Maximum Annual ROE = 9.07%
Minimum Annual Increase = -341.98%
Minimum Annual ROE = -40.66%
| Year | ROE | Change |
|---|---|---|
| 2024 | -40.66% | 85.18% |
| 2023 | -21.95% | -341.98% |
| 2022 | 9.07% | 228.93% |
| 2021 | 2.76% | 2.90% |
| 2020 | 0.09% | -96.50% |
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) Average ROE
How has 4195.TWO ROE performed in the past?
The current ROE of Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-17.85%
5-year avg
-10.14%
10-year avg
-8.01%
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) ROE vs. Peers
How is 4195.TWO’s ROE compared to its peers?
Genomics BioSci & Tech. Co.,Ltd.’s ROE is greater than Sunny Pharmtech Inc. (-27.76%), greater than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (-3.12%), greater than Advagene Biopharma Co., Ltd. (-34.85%), less than Greenyn Biotechnology Co., Ltd (16.29%), greater than NaviFUS Corp. (-20.42%), greater than Enimmune corporation (-70.32%), greater than Meribank Biotech Co., Ltd (-5.56%), greater than Hcmed (-53.25%), greater than GeneReach Biotechnology Corp. (-22.70%), greater than GlycoNex Incorporation (-21.46%),
| Company | ROE | Market cap |
|---|---|---|
| -27.76% | $2.01B | |
| -3.12% | $1.91B | |
| -34.85% | $1.67B | |
| 16.29% | $2.01B | |
| -20.42% | $1.44B | |
| -70.32% | $1.48B | |
| -5.56% | $1.53B | |
| -53.25% | $2.41B | |
| -22.70% | $1.12B | |
| -21.46% | $2.69B |
Build a custom stock screener for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomics BioSci & Tech. Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Genomics BioSci & Tech. Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Genomics BioSci & Tech. Co.,Ltd.'s ROE?
How is the ROE calculated for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)?
What is the highest ROE for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)?
What is the 3-year average ROE for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)?
What is the 5-year average ROE for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)?
How does the current ROE for Genomics BioSci & Tech. Co.,Ltd. (4195.TWO) compare to its historical average?